FDA Investigator: Laurimer Kuilan-Torres
- Laurimer Kuilan-Torres first started conducting FDA inspections in 2015, with the last inspection in 2024. Over that time, Laurimer Kuilan-Torres has conducted 70 inspections at 64 companies across 66 sites.
Get Laurimer Kuilan-Torres's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Baxter Pharmaceutical Solutions, Bloomington | 2024
Available Now - $199
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Smith & Nephew, Fort Worth | September 2022
Available Now - $199
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Zhejiang Tianyu Pharmaceutical, Taizhoushi | 2022
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Tianjin Asymchem Pharmaceuticals, Tianjin | Oct 2021
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Hangzhou Linkeweier Daily Chemicals, Hangzhou | 2019
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Excellence Medical Supplies, Changzhou | July 2019
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Bloomage Freda Biopharm, Jinan | April 2019
Available Now - $199
Laurimer Kuilan-Torres
Animal Drugs & Feed Form 483
FDA 483 Zhejiang Tianyu Pharmaceutical, Taizhoushi | 2019
Available Now - $199
Laurimer Kuilan-Torres
Animal Drugs & Feed Form 483
FDA 483 Baxter Healthcare, Jayuya | December 2018
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Ex-Lax, Humacao | November 2018
Available Now - $199
Laurimer Kuilan-Torres
Animal Drugs & Feed Form 483
FDA EIR Precision Nuclear of Virginia, Salem | November 2015
Available Now - $995
Laurimer Kuilan-Torres
Human Drug Form 483
483 Response Precision Nuclear of Virginia, Salem | Nov 2015
Available Now - $299
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Janssen Ortho, Gurabo | May 2015
Available Now - $199
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 FUJIFILM Diosynth Biotechnologies Texas, LLC, College Station | 2023
Out-of-stock
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Takeda Pharmaceutical Company Limited, Hikari | 2023
Out-of-stock
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Ajinomoto Althea, Inc., San Diego | 2023
Out-of-stock
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Kashiv BioSciences, LLC, Chicago | 2022
Out-of-stock
Laurimer Kuilan-Torres
Human Drugs Form 483
FDA 483 Yabao Pharmaceutical Co., Ltd. Beijing, Beijing | 2022
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Jiangxi Aifeimu Technology Co., Ltd., Wannian City | 2019
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Zhejiang Regen Chemical Co., Ltd., Taizhou | 2019
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Jiangsu Province Jianerkang Medical Dressing Co., Ltd, Changzhou | 2019
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 IPR Pharmaceuticals, Inc., Canovanas | 2018
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Qingdao University of Science and Technology, Qingdao | 2018
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site), Jinan | 2018
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Teena Biolabs Pvt Ltd, Bachupally | 2018
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 RA Chem Pharma Limited, Hyderabad | 2018
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Fenwal International, Inc., Maricao | 2017
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Apotex Inc., North York | 2017
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
FDA 483 Teva Czech Industries s.r.o., Opava 9 | 2017
Out-of-stock
Laurimer Kuilan-Torres
Human Drug Form 483
Co-Investigators (37)
- Ruo H. Xu, FDA Investigator
- Yiwei Li, FDA Investigator
- Lindsey J. Brown, FDA Investigator
- Holly Brevig, FDA Investigator
- Thuy T. Nguyen, FDA Investigator
- Vidya B. Pai, FDA Investigator
- Bingchen Du, FDA Investigator
- Esther C. Broner, FDA Investigator
- Muna Algharibeh, FDA Investigator
- Lane V. Christensen, FDA Investigator
- Tonia F. Bernard, FDA Investigator
- Marcus A. Ray, FDA Investigator
- Dennis Cantellops Paite, FDA Investigator
- Jose E. Melendez, FDA Investigator
- Miguel A. Martinez, FDA Investigator
- Kumar G. Janoria, FDA Investigator
- Hala L. Selby, FDA Investigator
- Christina A. Miller, FDA Investigator
- Vilmary Negron Rodriguez, FDA Investigator
- Marian E. Ramirez, FDA Investigator
- Joan M. Cantellops Figueroa, FDA Investigator
- Jose A. Lopez Rubet, FDA Investigator
- Cantellops Figueroa, Joan M, FDA Investigator
- Lopez Rubet, Jose A, FDA Investigator
- Ariel Cruz Figueroa, FDA Investigator
- David L. Chon, FDA Investigator
- Roger F. Zabinski, FDA Investigator
- Djamila Harouaka, FDA Investigator
- Liming Zhang, FDA Investigator
- Saied A. Asbagh, FDA Investigator
- Binh T. Nguyen, FDA Investigator
- Jose F. Velez, FDA Investigator
- Stephanie D. Crockett, FDA Investigator
- Jorge L. Lajara, FDA Investigator
- Eva I. Merced Medina, FDA Investigator
- Merced Medina, Eva I, FDA Investigator
- Loreily Figueroa Agrinsoni, FDA Investigator